Protalix BioTherapeutics (PLX) Change in Inventory (2010 - 2026)

Protalix BioTherapeutics' Change in Inventory history runs 17 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 373.17% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $11.0 million (up 486.2% YoY), while the FY2025 annual figure was $4.5 million, up 104.09% from the prior year.
• Change in Inventory was $4.7 million for Q1 2026 at Protalix BioTherapeutics, up from $4.5 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $4.7 million in Q1 2026 to a low of -$3.5 million in Q3 2024.
• Historically, Change in Inventory has averaged $736470.6 across 5 years, with a median of $124000.0 in 2025.
• The sharpest annual moves came in 2023 and 2026: Change in Inventory sank 667.82% in 2023, then jumped 373.17% in 2026.
• A 5-year view of Change in Inventory shows it stood at $2.2 million in 2022, then tumbled by 213.2% to -$2.5 million in 2023, then jumped by 259.34% to $4.0 million in 2024, then increased by 10.63% to $4.5 million in 2025, then climbed by 6.06% to $4.7 million in 2026.
• The last three Change in Inventory figures came in at $4.7 million (Q1 2026), $4.5 million (Q4 2025), and $124000.0 (Q3 2025), per Business Quant data.